-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $13

Benzinga·05/08/2025 16:54:50
Listen to the news
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $14 to $13.